Dr Reddy’s Q2 Forecast Shows Mixed Signals as US Sales Dip
Dr Reddy's Laboratories is poised for a quarter of moderate growth as it navigates mixed global markets, with domestic demand offering some relief against softening US sales. Investors and analysts...
Read more










